Breakthroughs and Setbacks: New Data Highlights Promise and Risk in Cell and Gene Therapies 3 months ago ByJohnIn Biopharma HighlightsPharma Industry Updates
Biodexa Pharmaceuticals Reports Interim Results Highlighting Strategic Advances in Rare Disease Pipeline and Clinical Progress 3 months ago ByJohnIn Clinical TrialsInnovationPharma Industry UpdatesResearch Updates
Atea Pharmaceuticals Advances Global Phase 3 HCV Program with First Patient Dosed in C-FORWARD Outside North America 3 months ago ByJohnIn Clinical TrialsInnovationPartnershipsPharma Industry UpdatesResearch Updates
Hikma Pharmaceuticals Invests $1 Billion to Expand U.S. Generic Drug Manufacturing Capabilities and Announces Sustainability Goals 3 months ago ByJohnIn Biopharma ManufacturingInnovationLeadersPharma Industry Updates
aTyr Pharma Added to Russell 2000® and Russell 3000® Indexes, Reflecting Growth and Market Confidence 3 months ago ByJohnIn Biopharma HighlightsInnovationInvestmentsPeoplePharma Industry Updates
Oncolytics Biotech Highlights Growing Investor Interest as Global Oncology Drug Market Surpasses $900 Billion Forecast 3 months ago ByJohnIn Biopharma HighlightsClinical TrialsInnovationInvestments
Viking Therapeutics Launches Phase 3 VANQUISH Program for VK2735 in Obesity and Type 2 Diabetes 3 months ago ByJohnIn BreakthroughsClinical TrialsInnovationPharma Industry UpdatesResearch Updates
Metabolics Pharma Announces Positive Topline Results from Phase 1a Clinical Trial of ENT-03 in Obese and Diabetic Subjects 3 months ago ByJohnIn BreakthroughsClinical TrialsInnovationPharma Industry UpdatesResearch Updates
MaaT Pharma Delivers Business Update Amid Positive Clinical and Commercial Milestones 3 months ago ByJohnIn Biopharma HighlightsClinical TrialsInnovationPartnershipsPharma Industry Updates
CagriSema Demonstrates Significant Weight Loss in REDEFINE Clinical Trials, Offering New Hope for Obesity and Type 2 Diabetes Management 3 months ago ByJohnIn BreakthroughsClinical TrialsInnovationPharma Industry UpdatesResearch Updates
Ocular Therapeutix Advances OTX-TKI Axitinib Hydrogel with Positive Phase 1/2 and Registrational Trial Data 4 months ago ByJohnIn Biopharma ManufacturingClinical TrialsInnovationPharma Industry UpdatesTechnology
FDA Approves Dupilumab for Bullous Pemphigoid in Landmark Win for Sanofi and Regeneron 4 months ago ByJohnIn Biopharma HighlightsClinical TrialsFDA ApprovalsPeoplePharma Industry Updates
FDA Approves Nitisinone (HARLIKU) for Alkaptonuria: First Therapy for Rare Genetic Disorder Marks Milestone in Metabolic Disease 4 months ago ByJohnIn BreakthroughsFDA ApprovalsPeopleResearch Updates
Zealand Pharma Reports Positive Phase 1b Results for Dual GLP-1/GLP-2 Agonist Dapiglutide in Obesity and Metabolic Disease 4 months ago ByJohnIn Biopharma HighlightsBreakthroughsClinical TrialsInnovationResearch Updates
Clarity Pharmaceuticals and SpectronRx Announce Major U.S. Manufacturing Deal for 64Cu-SAR-bisPSMA Radiopharmaceutical 4 months ago ByJohnIn Biopharma ManufacturingClinical TrialsPartnershipsPharma Industry UpdatesTechnology
